Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.37 |
| ▸ | CA12 | O43570 | 2/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | CA3 | P07451 | 2/20 | 0.37 |
| ▸ | CA4 | P22748 | 2/20 | 0.37 |
| ▸ | CA6 | P23280 | 2/20 | 0.37 |
| ▸ | CA5A | P35218 | 2/20 | 0.37 |
| ▸ | CA7 | P43166 | 2/20 | 0.37 |
| ▸ | CA9 | Q16790 | 2/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.37 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | GSR | P00390 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7420541 | 0.97 | DNM1 (0.38) | NFKB1DNM1CA12CA1CA2 | |
| SCHEMBL6577127 | 0.97 | DNM1 (0.42) | NFKB1DNM1CA12CA1CA2 | |
| SCHEMBL6575209 | 0.97 | DNM1 (0.42) | NFKB1DNM1CA12CA1CA2 | |
| SCHEMBL219409 | 0.92 | — | — | |
| Ammonia Solution, Strong SCHEMBL7766691 | 0.89 | NFKB1 (0.32) | NFKB1DNM1CA12CA1CA2 | |
| Hydrochloric Acid SCHEMBL7420560 | 0.89 | DNM1 (0.33) | NFKB1DNM1CA12CA1CA2 | |
| Iodomethane SCHEMBL4650590 | 0.86 | NFKB1 (0.30) | NFKB1 | |
| SCHEMBL6298010 | 0.85 | SMPD1 (0.32) | — | |
| SCHEMBL7934735 | 0.82 | SMPD1 (0.36) | — | |
| SCHEMBL7934687 | 0.82 | SMPD1 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024040745-A1 | AMIDE COMPOUND CONTAINING IODO ARYL OR IODO HETEROARYL, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 科睿驰（深圳）医疗科技发展有限公司 | 2024-02-29 | — | — | WO | disclosed |
| EP-3475257-B1 | ACETALANTHRAQUINONE DERIVATIVES USEFUL FOR CELLULAR STAINING | BIOSTATUS LTD (GB) | 2023-06-07 | — | — | EP | disclosed |
| EP-3475257-B1 | ACETALANTHRAQUINONE DERIVATIVES USEFUL FOR CELLULAR STAINING | BIOSTATUS LTD (GB) | 2023-06-07 | — | — | EP | disclosed |
| US-11447638-B2 | Acetalanthraquinone derivatives useful for cellular staining | BIOSTATUS LIMITED (GB) | 2022-09-20 | — | — | US | disclosed |
| US-11447638-B2 | Acetalanthraquinone derivatives useful for cellular staining | BIOSTATUS LIMITED (GB) | 2022-09-20 | — | — | US | disclosed |
| US-10759814-B2 | Pharmaceutical compositions containing substituted polycyclic pyridone derivatives and prodrug thereof | SHIONOGI & CO., LTD. (JP) | 2020-09-01 | — | — | US | disclosed |
| US-20190249011-A1 | ACETALANTHRAQUINONE DERIVATIVES USEFUL FOR CELLULAR STAINING | BIOSTATUS LIMITED (GB) | 2019-08-15 | — | — | US | disclosed |
| US-20190249011-A1 | ACETALANTHRAQUINONE DERIVATIVES USEFUL FOR CELLULAR STAINING | BIOSTATUS LIMITED (GB) | 2019-08-15 | — | — | US | disclosed |
| US-20190169206-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUG THEREOF | SHIONOGI & CO., LTD. (JP) | 2019-06-06 | — | — | US | disclosed |
| EP-3475257-A1 | ACETALANTHRAQUINONE DERIVATIVES USEFUL FOR CELLULAR STAINING | Biostatus Limited (GB) | 2019-05-01 | — | — | EP | disclosed |
| WO-2017220969-A1 | ACETALANTHRAQUINONE DERIVATIVES USEFUL FOR CELLULAR STAINING | BIOSTATUS LIMITED (GB) | 2017-12-28 | — | — | WO | disclosed |
| US-20160207879-A1 | METHODS AND INDUSTRIAL PROCESSES FOR THE GENERATION OF FREE FATTY ACIDS AND DERIVATIVES THEREOF FROM OIL GUMS | INVENTURE RENEWABLES INC (US) | 2016-07-21 | — | — | US | disclosed |
| WO-2015050656-A2 | METHODS AND INDUSTRIAL PROCESSES FOR THE GENERATION OF FREE FATTY ACIDS DERIVATIVES THEREOF FROM OIL GUMS | INVENTURE RENEWABLES, INC. (US) | 2015-04-09 | — | — | WO | disclosed |
| EP-0817776-B1 | FORMALDEHYDE-FREE 1,3,5-TRIAZINE BASED CROSSLINKERS | CYTEC TECH CORP (US) | 2004-05-06 | — | — | EP | disclosed |
| US-5783642-A | Coating compositions containing 1,3,5-triazine compounds substituted with acetal and/or cyclized acetal-based groups | CYTEC INDUSTRIES INC. (US) | 1998-07-21 | — | — | US | disclosed |
| US-5777040-A | Curable compositions containing 1,3,5-triazine compounds substituted with acetal and/or cyclized acetal-based groups | CYTEC TECHNOLOGY CORP. (US) | 1998-07-07 | — | — | US | disclosed |
| EP-0817776-A1 | FORMALDEHYDE-FREE 1,3,5-TRIAZINE BASED CROSSLINKERS | CYTEC TECHNOLOGY CORP. (US) | 1998-01-14 | — | — | EP | disclosed |
| US-5672703-A | CURING AGENTS | CYTEC TECHNOLOGY CORP. (US) | 1997-09-30 | — | — | US | disclosed |
| WO-1996029318-A1 | FORMALDEHYDE-FREE 1,3,5-TRIAZINE BASED CROSSLINKERS | CYTEC TECHNOLOGY CORP. (US) | 1996-09-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190169206-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUG THEREOF | TYMP, PNP, CYP3A4 | NFKB1 1957/4885DNM1 3963/4885CA12 4580/4885 |
| US-11447638-B2 | Acetalanthraquinone derivatives useful for cellular staining | ERH, NR2E3, NR0B2 | NFKB1 2800/4885DNM1 1992/4885CA12 1060/4885 |
| US-10759814-B2 | Pharmaceutical compositions containing substituted polycyclic pyridone derivatives and prodrug thereof | TYMP, PNP, CYP3A4 | NFKB1 1957/4885DNM1 3963/4885CA12 4580/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.